About this Research Topic
Drug-resistant infections among critically ill
Critical care or intensive care has always been one of the most delicate areas of healthcare given the often vulnerable nature of the patients requiring such care. This has only become more prevalent during and following the COVID-19 pandemic which crippled many healthcare systems worldwide. However, one of the key aspects of critical care is the prevention and treatment of antibiotic and antimicrobial resistant infections occurring amongst this vulnerable population. Much focus has been dedicated to the emergence of ‘super bugs’ in hospitals, however, drug resistant infections can be brought in a large manner of ways.
This Research Topic examines the prevalence and impact of drug resistant infections among critically ill patients. The collection explore how existing antibiotic therapies may not be sufficient to treat these infections, as well as the potential implications for patient care and outcomes. We aim at providing important insights into the challenges posed by antimicrobial resistance in critical illness settings.
We welcome the submission of articles focusing on, but limited to, the following topics:
• trends in drug resistance, such as variation of severity or differences between age groups
• strategies for managing this growing public health threat
• Understanding the mechanisms that enable bacteria to become resistant to antibiotics in a clinical setting
• developing new treatments that can overcome drug resistance in critically ill patients
• Identifying risk factors associated with acquiring a drug-resistant infection while hospitalized
Critical care or intensive care has always been one of the most delicate areas of healthcare given the often vulnerable nature of the patients requiring such care. This has only become more prevalent during and following the COVID-19 pandemic which crippled many healthcare systems worldwide. However, one of the key aspects of critical care is the prevention and treatment of antibiotic and antimicrobial resistant infections occurring amongst this vulnerable population. Much focus has been dedicated to the emergence of ‘super bugs’ in hospitals, however, drug resistant infections can be brought in a large manner of ways.
This Research Topic examines the prevalence and impact of drug resistant infections among critically ill patients. The collection explore how existing antibiotic therapies may not be sufficient to treat these infections, as well as the potential implications for patient care and outcomes. We aim at providing important insights into the challenges posed by antimicrobial resistance in critical illness settings.
We welcome the submission of articles focusing on, but limited to, the following topics:
• trends in drug resistance, such as variation of severity or differences between age groups
• strategies for managing this growing public health threat
• Understanding the mechanisms that enable bacteria to become resistant to antibiotics in a clinical setting
• developing new treatments that can overcome drug resistance in critically ill patients
• Identifying risk factors associated with acquiring a drug-resistant infection while hospitalized
Keywords: Antibiotic Resistance, Clinical Practice, ICU, Critical Care
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
